Antihistamine medication
This article is about the drug. For the Roman province, see Tripolitania. For the city, see Tripoli.
Pharmaceutical compound
Triprolidine is an over-the-counter first-generation antihistamine with strong anticholinergic properties.[1] It is used to combat the symptoms associated with allergies and is sometimes combined with other medications in preparations designed to provide general relief for flu-like symptoms.[2] As with many antihistamines, the most common side effect is drowsiness.[1]
Triprolidine was patented in 1948 and came into medical use in 1953,[3] and has mostly been replaced in popular cold and flu medications by other drugs such as diphenhydramine, promethazine, chlorpheniramine, loratadine and fexofenadine.
See also
References
- 1 2 Goldsmith P, Dowd PM (January 1993). "The new H1 antihistamines. Treatment of urticaria and other clinical problems". Dermatologic Clinics. 11 (1): 87–95. doi:10.1016/S0733-8635(18)30285-7. PMID 8094649.
- ↑ Williams BO, Liao SH, Lai AA, Arnold JD, Perkins JG, Blum MR, Findlay JW (1984). "Bioavailability of pseudoephedrine and triprolidine from combination and single-ingredient products". Clinical Pharmacy. 3 (6): 638–43. PMID 6509877.
- ↑ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 546. ISBN 9783527607495.
| Benzimidazoles (*) | |
|---|---|
| Diarylmethanes |
|
| Ethylenediamines | |
| Tricyclics | |
| Others |
|
| For topical use | |
| mAChRsTooltip Muscarinic acetylcholine receptors |
| ||||
|---|---|---|---|---|---|
| Precursors (and prodrugs) | |||||
